APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study (Q24305221)

triglyceride metabolic process

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

1 reference

coronary artery disease

1 reference

Philippa J Talmud

1

Philippa J

Talmud

1 reference

20 April 2024

Marja-Riitta Taskinen

object named as

Marja-Riitta Taskinen

3

Marja-Riitta

Taskinen

1 reference

20 April 2024

6

Y Antero Kesäniemi

Y Antero

Kesäniemi

1 reference

20 April 2024

Steve Martin

2

Steve

Martin

1 reference

20 April 2024

M Heikki Frick

4

M Heikki

Frick

1 reference

20 April 2024

Markku S Nieminen

5

Markku S

Nieminen

1 reference

20 April 2024

Amos Pasternack

7

Amos

Pasternack

1 reference

20 April 2024

Steve E Humphries

8

Steve E

Humphries

1 reference

20 April 2024

Mikko Syvänne

9

Mikko

Journal of Lipid Research

Syvänne

1 reference

20 April 2024

language of work or name

English

0 references

publication date

April 2004

0 references

published in

0 references

volume

45

0 references

page(s)

750-6

0 references

issue

4

0 references

cites work

An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

The apoAI-CIII-AIV gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Minimal haplotype tagging

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

T-1131-->C polymorphism within the apolipoprotein AV gene in hypertriglyceridemic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Structure and interfacial properties of human apolipoprotein A-V

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

7 January 2021

A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. The rationale, design, and baseline characteristics of the LOCAT St

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

7 January 2021

Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

7 January 2021

Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

7 January 2021

Apolipoprotein AIV Gene Variant S347 Is Associated With Increased Risk of Coronary Heart Disease and Lower Plasma Apolipoprotein AIV Levels

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300458-JLR200

7 January 2021